SEI Investments’s Organogenesis Holdings ORGO Stock Holding History

SEI Investments’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$97.8K	Hold	40,244	–	–	﹤0.01%	3187
2026 Q1	$95.4K	Buy	+40,244	New	+$139K	﹤0.01%	3102
2025 Q3	–	Sell	-108,543	Closed	-$397K	–	2886
2025 Q2	$397K	Sell	108,543 -53,563	-33%	-$200K	﹤0.01%	2280
2025 Q1	$700K	Sell	162,106 -27,308	-14%	-$110K	﹤0.01%	2025
2024 Q4	$606K	Sell	189,414 -57,998	-23%	-$195K	﹤0.01%	2120
2024 Q3	$708K	Sell	247,412 -29,606	-11%	-$83K	﹤0.01%	2066
2024 Q2	$776K	Hold	277,018	–	–	﹤0.01%	2003
2024 Q1	$787K	Buy	277,018 +28,905	+12%	+$98.2K	﹤0.01%	1974
2023 Q4	$1.01M	Hold	248,113	–	–	﹤0.01%	1873
2023 Q3	$789K	Buy	248,113 +14,397	+6%	+$45.7K	﹤0.01%	1960
2023 Q2	$776K	Buy	233,716 +200,616	+606%	+$593K	﹤0.01%	1973
2023 Q1	$70.5K	Buy	33,100 +17,963	+119%	+$44.4K	﹤0.01%	2607
2022 Q4	$40.7K	Buy	+15,137	New	+$44.2K	﹤0.01%	2494
2021 Q4	–	Sell	-95,752	Closed	-$1.36M	–	2643
2021 Q3	$1.36M	Buy	95,752 +39,590	+70%	+$615K	﹤0.01%	1658
2021 Q2	$928K	Buy	56,162 +28,734	+105%	+$536K	﹤0.01%	1843
2021 Q1	$500K	Buy	+27,428	New	+$372K	﹤0.01%	2022

Other funds holding ORGO

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

SEI Investments's ORGO Position: Q2 2026 in Review

SEI Investments held its Organogenesis Holdings (ORGO) position steady in Q2 2026 at 40,244 shares worth $97.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3187.

SEI Investments first reported a position in ORGO in Q1 2021 and has held it in 16 quarters since. The position peaked at $1.36M in Q3 2021. 134 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

SEI Investments held 40,244 shares of Organogenesis Holdings worth $97.8K as of Q2 2026.
SEI Investments left its Organogenesis Holdings share count unchanged in Q2 2026.
Organogenesis Holdings made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #3187 holding.
SEI Investments first reported a position in Organogenesis Holdings in Q1 2021 and has held it in 16 quarters since.
SEI Investments's Organogenesis Holdings position peaked at $1.36M in Q3 2021.
134 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.